Abbreviation	Full Name
MSNs	mesoporous silica nanoparticles
BBB	blood–brain barrier
NP	nanoparticle
MRI	magnetic resonance imaging
Gd-Si-DTTA	gadolinium (trimethoxysilylpropyl)diethylene triaminetetraacetate
SPION	superparamagnetic iron oxide nanoparticles
Dy-DOTA	molecular Dy-complex
PEI	poly(ethylenimine)
RNA	ribonucleic acid
ROS	reactive oxygen species
MSN type SBA-15 (Santa Barbara Amorphous)	a well-ordered MSN with hexagonal pore arrangement and uniform pore sizes up to 30 nm
rh-BMP-2	bone morphogenetic protein 2 human
DNA	deoxyribonucleic acid
MDA-MB-231	a highly aggressive, invasive and poorly differentiated triple-negative breast cancer (TNBC) cell line as it lacks oestrogen receptor (ER) and progesterone receptor (PR) expression
MCF-7 cells	a human breast cancer cell line with estrogen, progesterone and glucocorticoid
cRGD	arginine-glycine-aspartic acid peptide-conjugated hollow mesoporous carbon
PGT	propoxylated glyceryl triacylate
PEG	poly(ethylene glycol)
PLA	poly(lactic acid)
(HepG2) cells	nontumourigenic cells with high proliferation rates and an epithelial-like morphology that perform many differentiated hepatic functions
MG-63 cells	osteosarcoma cells
TNF	tumour necrosis factor alpha
CYT-6091	anticancer medicine obtained by pegylation of the gold nanoparticles, accomplished by binding thiolated polyethylene glycol in between the TNF molecules on the surface of the gold nanoparticles